Public Participation in U.S. Food and Drug Administration (FDA) Advisory Committees: A Qualitative Analysis

Paper. Propes C, Montgomery T, Cheung K et al.. Therapeutic Innovation & Regulatory Science, 7 Nov 2026.

Tags: Human, MDMA, PTSD.

Weekly Science Digest, 6 Nov 2026 to 12 Nov 2026, finding 5: In brief

qualitative analysis of FDA advisory committee public comments, including the midomafetamine PTSD review

Read the original

—
Node—
Statuslive
Throughput—